Cargando…
The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy
BACKGROUND: Hepatitis C affects over 185 million people around the world. This silent disease is responsible for up to 700,000 deaths per year. Despite the scientific revolution in diagnosis and treatment, hepatitis C control remains a huge challenge due to the cost of effective medications. In resp...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094040/ https://www.ncbi.nlm.nih.gov/pubmed/27806712 http://dx.doi.org/10.1186/s12889-016-3784-4 |
_version_ | 1782465048747180032 |
---|---|
author | Mesquita, Fabio Santos, Melina Erica Benzaken, Adele Corrêa, Renato Girade Cattapan, Elisa Sereno, Leandro Soares Naveira, Marcelo Contardo Moscoso |
author_facet | Mesquita, Fabio Santos, Melina Erica Benzaken, Adele Corrêa, Renato Girade Cattapan, Elisa Sereno, Leandro Soares Naveira, Marcelo Contardo Moscoso |
author_sort | Mesquita, Fabio |
collection | PubMed |
description | BACKGROUND: Hepatitis C affects over 185 million people around the world. This silent disease is responsible for up to 700,000 deaths per year. Despite the scientific revolution in diagnosis and treatment, hepatitis C control remains a huge challenge due to the cost of effective medications. In response to the global outcry of hepatitis epidemic and the need to improve the nation’s public health response, the Ministry of Health of Brazil revolutionized hepatitis C treatment by incorporating highly effective drugs that can be accessed through sustainable and universal means. DISCUSSION: This paper describes the unique process of implementing evidence-informed policy to respond to hepatitis C epidemic through the update of hepatitis C treatment in Brazil based on the estimate of disease prevalence, current international guidelines, and the cost-effectiveness impact in the Brazilian Unified Health System. Through a debate of an experience report, the authors underlie the strategic plan implemented according to the situation analysis that emphasized the need to improve its current response over a relatively short-term period. The comprehensive response is detailed comprising three main objectives: improve treatment outcomes by evaluating and incorporating new and effective medications at a sustainable price; elaborate on clinical guidelines to treat hepatitis C patients; and develop awareness and diagnosis campaigns targeted at the population of interest. In this scenario, Brazil was able to obtain an unprecedented discount for a high-medium income country; provided treatment to more than 7000 individuals in the last 2 months of 2015; and expects to treat 38,000 new patients in 2016. SUMMARY: The remarkable process applied in Brazil was developed according to epidemiological data and scientific evidence, and it was motivated by the engagement of the country in the Sustainable Development Goals, which may inspire other developing countries to identify ways to achieve these goals by 2030. |
format | Online Article Text |
id | pubmed-5094040 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50940402016-11-07 The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy Mesquita, Fabio Santos, Melina Erica Benzaken, Adele Corrêa, Renato Girade Cattapan, Elisa Sereno, Leandro Soares Naveira, Marcelo Contardo Moscoso BMC Public Health Debate BACKGROUND: Hepatitis C affects over 185 million people around the world. This silent disease is responsible for up to 700,000 deaths per year. Despite the scientific revolution in diagnosis and treatment, hepatitis C control remains a huge challenge due to the cost of effective medications. In response to the global outcry of hepatitis epidemic and the need to improve the nation’s public health response, the Ministry of Health of Brazil revolutionized hepatitis C treatment by incorporating highly effective drugs that can be accessed through sustainable and universal means. DISCUSSION: This paper describes the unique process of implementing evidence-informed policy to respond to hepatitis C epidemic through the update of hepatitis C treatment in Brazil based on the estimate of disease prevalence, current international guidelines, and the cost-effectiveness impact in the Brazilian Unified Health System. Through a debate of an experience report, the authors underlie the strategic plan implemented according to the situation analysis that emphasized the need to improve its current response over a relatively short-term period. The comprehensive response is detailed comprising three main objectives: improve treatment outcomes by evaluating and incorporating new and effective medications at a sustainable price; elaborate on clinical guidelines to treat hepatitis C patients; and develop awareness and diagnosis campaigns targeted at the population of interest. In this scenario, Brazil was able to obtain an unprecedented discount for a high-medium income country; provided treatment to more than 7000 individuals in the last 2 months of 2015; and expects to treat 38,000 new patients in 2016. SUMMARY: The remarkable process applied in Brazil was developed according to epidemiological data and scientific evidence, and it was motivated by the engagement of the country in the Sustainable Development Goals, which may inspire other developing countries to identify ways to achieve these goals by 2030. BioMed Central 2016-11-02 /pmc/articles/PMC5094040/ /pubmed/27806712 http://dx.doi.org/10.1186/s12889-016-3784-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Debate Mesquita, Fabio Santos, Melina Erica Benzaken, Adele Corrêa, Renato Girade Cattapan, Elisa Sereno, Leandro Soares Naveira, Marcelo Contardo Moscoso The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy |
title | The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy |
title_full | The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy |
title_fullStr | The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy |
title_full_unstemmed | The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy |
title_short | The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy |
title_sort | brazilian comprehensive response to hepatitis c: from strategic thinking to access to interferon-free therapy |
topic | Debate |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094040/ https://www.ncbi.nlm.nih.gov/pubmed/27806712 http://dx.doi.org/10.1186/s12889-016-3784-4 |
work_keys_str_mv | AT mesquitafabio thebraziliancomprehensiveresponsetohepatitiscfromstrategicthinkingtoaccesstointerferonfreetherapy AT santosmelinaerica thebraziliancomprehensiveresponsetohepatitiscfromstrategicthinkingtoaccesstointerferonfreetherapy AT benzakenadele thebraziliancomprehensiveresponsetohepatitiscfromstrategicthinkingtoaccesstointerferonfreetherapy AT correarenatogirade thebraziliancomprehensiveresponsetohepatitiscfromstrategicthinkingtoaccesstointerferonfreetherapy AT cattapanelisa thebraziliancomprehensiveresponsetohepatitiscfromstrategicthinkingtoaccesstointerferonfreetherapy AT serenoleandrosoares thebraziliancomprehensiveresponsetohepatitiscfromstrategicthinkingtoaccesstointerferonfreetherapy AT naveiramarcelocontardomoscoso thebraziliancomprehensiveresponsetohepatitiscfromstrategicthinkingtoaccesstointerferonfreetherapy AT mesquitafabio braziliancomprehensiveresponsetohepatitiscfromstrategicthinkingtoaccesstointerferonfreetherapy AT santosmelinaerica braziliancomprehensiveresponsetohepatitiscfromstrategicthinkingtoaccesstointerferonfreetherapy AT benzakenadele braziliancomprehensiveresponsetohepatitiscfromstrategicthinkingtoaccesstointerferonfreetherapy AT correarenatogirade braziliancomprehensiveresponsetohepatitiscfromstrategicthinkingtoaccesstointerferonfreetherapy AT cattapanelisa braziliancomprehensiveresponsetohepatitiscfromstrategicthinkingtoaccesstointerferonfreetherapy AT serenoleandrosoares braziliancomprehensiveresponsetohepatitiscfromstrategicthinkingtoaccesstointerferonfreetherapy AT naveiramarcelocontardomoscoso braziliancomprehensiveresponsetohepatitiscfromstrategicthinkingtoaccesstointerferonfreetherapy |